메뉴 건너뛰기
Drugs and Therapy Perspectives
Volumn 10, Issue 3, 1997, Pages 13-16
Anthracycline maintenance therapy limited by risk of cardiotoxicity
[No Author Info available]
Author keywords

[No Author keywords available]
Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; FREE RADICAL;
EID: 0030857370     PISSN: 11720360     EISSN: None     Source Type: Journal    
DOI: 10.2165/00042310-199710030-00005     Document Type: Review
Times cited : (1)
References (13)
  • 1
    • 0030444894 scopus 로고    scopus 로고
    • A risk-benefit assessment of anthracycline antibiotics in antineoplastic therapy
    • Dec
    • Abraham R, Basser RL, Green MD. A risk-benefit assessment of anthracycline antibiotics in antineoplastic therapy. Drug Saf 1996 Dec; 15 (6): 406-29
    • (1996) Drug Saf , vol.15 , Issue.6 , pp. 406-429
    • Abraham, R.1    Basser, R.L.2    Green, M.D.3
  • 2
    • 26844530601 scopus 로고    scopus 로고
    • London: The Pharmaceutical Press
    • British National Formulary No. 33. London: The Pharmaceutical Press, 1997; 359-61
    • (1997) British National Formulary No. 33 , pp. 359-361
  • 3
    • 0028558733 scopus 로고
    • Dose optimization of anthracyclines
    • De Valeriola D. Dose optimization of anthracyclines. Anticancer Res 1994; 14: 2307-14
    • (1994) Anticancer Res , vol.14 , pp. 2307-2314
    • De Valeriola, D.1
  • 4
    • 1842660531 scopus 로고
    • Hepatotoxicity of chemotherapeutic agents
    • Perry MC, editor. Orlando: Grune and Stratton
    • Perry MC, Yarbro JN. Hepatotoxicity of chemotherapeutic agents. In: Perry MC, editor. Toxicity of chemotherapy. 1st ed. Orlando: Grune and Stratton, 1984: 297-315
    • (1984) Toxicity of Chemotherapy. 1st Ed. , pp. 297-315
    • Perry, M.C.1    Yarbro, J.N.2
  • 5
    • 0026714331 scopus 로고
    • The anthracyclines: Will we ever find a better doxorubicin?
    • Weiss RB. The anthracyclines: will we ever find a better doxorubicin? Semin Oncol 1992; 19(6): 670-86
    • (1992) Semin Oncol , vol.19 , Issue.6 , pp. 670-686
    • Weiss, R.B.1
  • 6
    • 0017354816 scopus 로고
    • Daunomycin-induced cardiotoxicity in children and adults: A review of 110 cases
    • Von Hoff DD, Rozencweig M, Layard M. Daunomycin-induced cardiotoxicity in children and adults: a review of 110 cases. Am J Med 1977; 62: 200-8
    • (1977) Am J Med , vol.62 , pp. 200-208
    • Von Hoff, D.D.1    Rozencweig, M.2    Layard, M.3
  • 7
    • 0021878134 scopus 로고
    • Early and delayed clinical cardiotoxicity of doxorubicin
    • Buzdar AV, Marcus C, Smith TL, et al. Early and delayed clinical cardiotoxicity of doxorubicin. Cancer 1985; 55: 2761-5
    • (1985) Cancer , vol.55 , pp. 2761-2765
    • Buzdar, A.V.1    Marcus, C.2    Smith, T.L.3
  • 8
    • 1842710657 scopus 로고
    • Radiation induced myocardial changes
    • Muggia FM, Green MD, Speyer JL, editors. Baltimore: The Johns Hopkins University Press
    • Renzi RS, Straus KL, Glatstein E. Radiation induced myocardial changes. In: Muggia FM, Green MD, Speyer JL, editors. Cancer treatment and the heart. 1st ed. Baltimore: The Johns Hopkins University Press, 1992; 287-328
    • (1992) Cancer Treatment and the Heart. 1st Ed. , pp. 287-328
    • Renzi, R.S.1    Straus, K.L.2    Glatstein, E.3
  • 9
    • 0028000315 scopus 로고
    • Anthracyclines: Cardiotoxicity and its prevention
    • Hale JP, Lewis IJ. Anthracyclines: cardiotoxicity and its prevention. Arch Dis Child 1994; 71: 457-62
    • (1994) Arch Dis Child , vol.71 , pp. 457-462
    • Hale, J.P.1    Lewis, I.J.2
  • 10
    • 0026709749 scopus 로고
    • Infusional anthracyclines: Is slower better? If so, why?
    • Workman P. Infusional anthracyclines: is slower better? If so, why? Ann Oncol 1992; 3: 591-4
    • (1992) Ann Oncol , vol.3 , pp. 591-594
    • Workman, P.1
  • 11
    • 0030835317 scopus 로고    scopus 로고
    • Liposomal doxorubicin is active against AIDS-related Kaposi's sarcoma
    • Jun 23
    • Liposomal doxorubicin is active against AIDS-related Kaposi's sarcoma. Drug Ther Perspect 1997 Jun 23; 9 (12): 1-5
    • (1997) Drug Ther Perspect , vol.9 , Issue.12 , pp. 1-5
  • 12
    • 0026585672 scopus 로고
    • ICRF-187 permits longer treatment with doxorubicin in women with breast cancer
    • Jan
    • Speyer JL, Green MD, Zeleniuch-Jacquotte A, et al. ICRF-187 permits longer treatment with doxorubicin in women with breast cancer. J Clin Oncol 1992 Jan; 10: 117-27
    • (1992) J Clin Oncol , vol.10 , pp. 117-127
    • Speyer, J.L.1    Green, M.D.2    Zeleniuch-Jacquotte, A.3
  • 13
    • 0027159174 scopus 로고
    • Epirubicin: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in cancer chemotherapy
    • Plosker GL, Faulds D. Epirubicin: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in cancer chemotherapy. Drugs 1993; 45 (5): 788-856
    • (1993) Drugs , vol.45 , Issue.5 , pp. 788-856
    • Plosker, G.L.1    Faulds, D.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.